THE SHARE: Change: -0.01 SEK (-4.65%) / Price: 0.18 SEK / May 19, 2025, 1:13 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Other

  • 23 May, 2024
    Spago Nanomedical erhåller avsiktsförklaringar från största ägare, styrelse och bolagsledning avseende nyttjande av TO12
  • 23 May, 2024
    Spago Nanomedical receives declarations of intent from the largest owner, board and management team regarding the exercise of TO12
  • 17 May, 2024
    Nyttjandeperioden för Spago Nanomedicals teckningsoptioner av serie TO12 inleds idag
  • 17 May, 2024
    The exercise period for Spago Nanomedical’s warrants of series TO12 commences today
  • 26 Mar, 2021
    Trading of Spago Nanomedical shares on Nasdaq First North Growth market starts today
  • 26 Mar, 2021
    Idag inleds handeln av Spago Nanomedicals aktie på Nasdaq First North Growth Market
  • 15 Mar, 2021
    Spago Nanomedical klara för handel på Nasdaq
  • 10 Mar, 2021
    Sista dag för handel med BTA
  • 2 Jun, 2020
    Sista dag för handel med BTA
  • 28 Mar, 2019
    Ytterligare 6,5 MSEK tillförs Spago Nanomedical
  • 1
  • 2
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2025 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications